vs
Bio-Techne（TECH）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是WSFS FINANCIAL CORP的1.1倍（$295.9M vs $275.3M），WSFS FINANCIAL CORP净利率更高（31.5% vs 12.8%，领先18.7%），WSFS FINANCIAL CORP同比增速更快（7.5% vs -6.4%），过去两年Bio-Techne的营收复合增速更高（4.2% vs 1.7%）
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
TECH vs WSFS — 直观对比
营收规模更大
TECH
是对方的1.1倍
$275.3M
营收增速更快
WSFS
高出13.9%
-6.4%
净利率更高
WSFS
高出18.7%
12.8%
两年增速更快
TECH
近两年复合增速
1.7%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $295.9M | $275.3M |
| 净利润 | $38.0M | $86.8M |
| 毛利率 | 64.6% | — |
| 营业利润率 | 18.4% | — |
| 净利率 | 12.8% | 31.5% |
| 营收同比 | -6.4% | 7.5% |
| 净利润同比 | 68.3% | 31.7% |
| 每股收益（稀释后） | $0.24 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TECHWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $295.9M | $271.9M | ||
| Q3 25 | — | $270.5M | ||
| Q2 25 | $317.0M | $267.5M | ||
| Q1 25 | $316.2M | $256.1M | ||
| Q4 24 | $297.0M | $261.5M | ||
| Q3 24 | $289.5M | $267.7M | ||
| Q2 24 | $306.1M | $266.0M |
净利润TECHWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $38.0M | $72.7M | ||
| Q3 25 | — | $76.4M | ||
| Q2 25 | $-17.7M | $72.3M | ||
| Q1 25 | $22.6M | $65.9M | ||
| Q4 24 | $34.9M | $64.2M | ||
| Q3 24 | $33.6M | $64.4M | ||
| Q2 24 | $40.6M | $69.3M |
毛利率TECHWSFS
| Q1 26 | — | — | ||
| Q4 25 | 64.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 62.7% | — | ||
| Q1 25 | 67.9% | — | ||
| Q4 24 | 65.3% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 66.4% | — |
营业利润率TECHWSFS
| Q1 26 | — | — | ||
| Q4 25 | 18.4% | 35.8% | ||
| Q3 25 | — | 37.3% | ||
| Q2 25 | -7.5% | 35.7% | ||
| Q1 25 | 12.2% | 34.0% | ||
| Q4 24 | 16.0% | 32.3% | ||
| Q3 24 | 13.8% | 31.9% | ||
| Q2 24 | 15.0% | 34.0% |
净利率TECHWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | 12.8% | 26.7% | ||
| Q3 25 | — | 28.3% | ||
| Q2 25 | -5.6% | 27.0% | ||
| Q1 25 | 7.1% | 25.7% | ||
| Q4 24 | 11.7% | 24.6% | ||
| Q3 24 | 11.6% | 24.1% | ||
| Q2 24 | 13.3% | 26.0% |
每股收益（稀释后）TECHWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.24 | $1.33 | ||
| Q3 25 | — | $1.37 | ||
| Q2 25 | $-0.11 | $1.27 | ||
| Q1 25 | $0.14 | $1.12 | ||
| Q4 24 | $0.22 | $1.08 | ||
| Q3 24 | $0.21 | $1.08 | ||
| Q2 24 | $0.26 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $172.9M | — |
| 总债务越低越好 | $260.0M | — |
| 股东权益账面价值 | $2.0B | $2.7B |
| 总资产 | $2.5B | $22.1B |
| 负债/权益比越低杠杆越低 | 0.13× | — |
8季度趋势，按日历期对齐
现金及短期投资TECHWSFS
| Q1 26 | — | — | ||
| Q4 25 | $172.9M | $1.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | $162.2M | — | ||
| Q1 25 | $140.7M | — | ||
| Q4 24 | $177.5M | $1.2B | ||
| Q3 24 | $187.5M | — | ||
| Q2 24 | $152.9M | — |
总债务TECHWSFS
| Q1 26 | — | — | ||
| Q4 25 | $260.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $346.0M | — | ||
| Q1 25 | $330.0M | — | ||
| Q4 24 | $300.0M | — | ||
| Q3 24 | $300.0M | — | ||
| Q2 24 | $319.0M | — |
股东权益TECHWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $2.0B | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | $1.9B | $2.7B | ||
| Q1 25 | $2.0B | $2.7B | ||
| Q4 24 | $2.1B | $2.6B | ||
| Q3 24 | $2.1B | $2.7B | ||
| Q2 24 | $2.1B | $2.5B |
总资产TECHWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $2.5B | $21.3B | ||
| Q3 25 | — | $20.8B | ||
| Q2 25 | $2.6B | $20.8B | ||
| Q1 25 | $2.6B | $20.5B | ||
| Q4 24 | $2.7B | $20.8B | ||
| Q3 24 | $2.7B | $20.9B | ||
| Q2 24 | $2.7B | $20.7B |
负债/权益比TECHWSFS
| Q1 26 | — | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
WSFS
暂无分部数据
